SC

Sudarshan Chemical Industries Ltd

Q4 FY26Chemicals & Petrochemicals

Sudarshan Chemical Industries Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,215
Market cap₹8.6K Cr
P/E465.3
Updated23 Aug 2026
Read4 min read

What the Q4 FY26 call signalled

0 of 3 strong

RevenueSlow growth
MarginMargins steady
CapexNo capex planned

The short version

The pigment industry has seen a global growth of 3-4% over the last 2-3 years, generally aligned with GDP growth. Entering FY27 with a stronger platform and clear execution agenda aiming for sustainable profitability.

From Sudarshan Chemical Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Slow growth
  • The pigment industry has seen a global growth of 3-4% over the last 2-3 years, generally aligned with GDP growth.
  • Sudarshan Chemical expects 8-10% volume growth in its legacy business for FY27.
  • Q4 showed a strong volume-led recovery with customers starting to buy again after destocking.
  • Integration of acquisitions and value capture initiatives are expected to drive EBITDA growth targeted at EUR 35 million for FY27.
  • The company anticipates no immediate capacity constraints, with sufficient headroom in both legacy and acquired plants for volume growth.
  • Demand outlook is cautiously optimistic despite geopolitical uncertainties; paint and housing markets (especially in the U.S.) expected to recover, supporting future demand.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Sudarshan Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

No capex planned
  • No specific current or future capex figures mentioned; however, the company states that for the projected 3-4 years of growth (EBITDA targets), no additional volume-related capex investment is required as there is enough capacity headroom in both legacy and acquired businesses.
  • The company has completed expansions in the Indian plant and has debottlenecking capacity left for growth.
  • Integration initiatives such as the One SAP Drive project (Integra) to integrate systems are underway, expected completion by year-end, which is a strategic IT investment.
  • The setting up of a Global Capability Center (GCC) has been initiated to improve operational efficiency.

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sudarshan Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided in the Sudarshan Chemical Industries Limited Q4 and FY26 earnings call does not explicitly mention the current or expected order book or pending orders. However, key relevant points related to demand and business outlook include: - Q4 showed strong volume recovery, driven by customers starting to buy after destocking. - Demand is currently muted, with customers cautious about inventory buildup due to geopolitical uncertainties. - Industry growth generally aligns with GDP, averaging 3%-4% globally. - Sudarshan is winning back customers and improving supply chain alignment, contributing to growth beyond just industry expansion.

2 more points management made on order book & pipeline

Sudarshan Chemical Industries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.8K Cr, net profit ₹82 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Vipul Organics Ltd (Q4 FY26)

    Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…

  • Chemfab Alkalis Ltd (Q4 FY26)

    Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key concall takeaways from Chemfab Alkalis Ltd's Q4 FY26 earnings call — and how it…

  • Sudarshan Pharma Industries Ltd (Q4 FY26)

    Revenue from Operations for Q4 March 2026: ₹220.92 Cr (Page 41) . Key concall takeaways from Sudarshan Pharma Industries Ltd's Q4 FY26 earnings call — and how…

  • Innovassynth Technologies (India) Ltd (Q4 FY26)

    Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Sudarshan Chemical Industries Ltd Q4 FY26 results?

The pigment industry has seen a global growth of 3-4% over the last 2-3 years, generally aligned with GDP growth. Entering FY27 with a stronger platform and clear execution agenda aiming for sustainable profitability.

What is Sudarshan Chemical Industries Ltd share price analysis?

Sudarshan Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 465.3 with a market cap of ₹8,633 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sudarshan Chemical Industries Ltd planning capital expenditure?

No specific current or future capex figures mentioned; however, the company states that for the projected 3-4 years of growth (EBITDA targets), no additional volume-related capex investment is required as there is enough capacity headroom in both legacy and acquired businesses.

Keep Sudarshan Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.